Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMD
2801
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$281M
| $618K | ﹤0.01% |
41,539
+494
| +1% | +$7.41K |
|
2802
TechTarget
TTGT
$276M
| $616K | ﹤0.01% |
114,113
+92,374
| +425% | +$497K |
|
2803
West Bancorporation
WTBA
$485M
| $616K | ﹤0.01% |
27,743
+4,784
| +21% | +$103K |
|
2804
Liquidity Services
LQDT
$1.35B
| $616K | ﹤0.01% |
20,309
+199
| +1% | +$5.35K |
|
2805
POSCO
PKX
$17.7B
| $613K | ﹤0.01% |
11,523
+4,234
| +58% | +$223K |
|
|
DEC
2806
Diversified Energy Company
DEC
$1.05B
| $612K | ﹤0.01% |
42,251
+9,069
| +27% | +$127K |
|
2807
First Bancorp
FNLC
$390M
| $611K | ﹤0.01% |
23,104
-833
| -3% | -$21.5K |
|
2808
Frontier Group Holdings
ULCC
$1.33B
| $610K | ﹤0.01% |
129,616
-20,825
| -14% | -$92.2K |
|
2809
iShares Short-Term National Muni Bond ETF
SUB
$11.6B
| $609K | ﹤0.01% |
5,709
| – | – |
|
2810
Peoples Financial Services
PFIS
$707M
| $609K | ﹤0.01% |
12,494
-2,179
| -15% | -$105K |
|
|
LOVE
2811
LoveSac
LOVE
$232M
| $608K | ﹤0.01% |
41,197
+15,114
| +58% | +$214K |
|
2812
Protagonist Therapeutics
PTGX
$10B
| $607K | ﹤0.01% |
6,954
-1,616
| -19% | -$132K |
|
|
SFD
2813
Smithfield Foods
SFD
$8.78B
| $607K | ﹤0.01% |
27,193
-2,649
| -9% | -$58.3K |
|
|
EFSI
2814
Eagle Financial Services Inc
EFSI
$227M
| $606K | ﹤0.01% |
15,220
+601
| +4% | +$22.5K |
|
2815
Abeona Therapeutics
ABEO
$347M
| $604K | ﹤0.01% |
114,520
+80,908
| +241% | +$407K |
|
|
ATYR
2816
aTyr Pharma
ATYR
$52M
| $603K | ﹤0.01% |
+769,820
| New | +$632K |
|
2817
TFS Financial
TFSL
$4.95B
| $602K | ﹤0.01% |
44,959
+20,361
| +83% | +$279K |
|
2818
Brookdale Senior Living
BKD
$2.89B
| $601K | ﹤0.01% |
55,654
+12,440
| +29% | +$122K |
|
2819
Lands' End
LE
$377M
| $598K | ﹤0.01% |
41,182
-2,804
| -6% | -$43.3K |
|
2820
Mayville Engineering Co
MEC
$540M
| $597K | ﹤0.01% |
31,908
-27,632
| -46% | -$451K |
|
2821
Utah Medical Products
UTMD
$228M
| $596K | ﹤0.01% |
10,649
-4,757
| -31% | -$276K |
|
|
CGMM
2822
Capital Group U.S. Small and Mid Cap ETF
CGMM
$3.4B
| $594K | ﹤0.01% |
20,607
| – | – |
|
2823
Inhibrx
INBX
$1.54B
| $593K | ﹤0.01% |
7,501
+1,503
| +25% | +$102K |
|
2824
Northeast Bank
NBN
$1.11B
| $591K | ﹤0.01% |
5,691
-269
| -5% | -$25.1K |
|
2825
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.38B
| $591K | ﹤0.01% |
26,950
+7,153
| +36% | +$157K |
|
Similar funds
Cliff Asness's Q4 2025 Portfolio in Review
As of Q4 2025, Cliff Asness held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- Cliff Asness's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- Cliff Asness added most to Atlassian in Q4 2025, an estimated $905M increase.
- Cliff Asness's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- Cliff Asness fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- Cliff Asness's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- Cliff Asness opened 211 new positions and closed 105 in Q4 2025.
- Cliff Asness's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.